Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Sales | 1,843,000 | 12,680,000 | 13,264,000 | 13,118,000 | 1,155,000 |
| Cost of Goods | 443,000 | 2,602,000 | 2,576,000 | 2,433,000 | 814,000 |
| Gross Profit | 1,400,000 | 10,078,000 | 10,688,000 | 10,685,000 | 341,000 |
| Operating Expenses | 6,328,000 | 7,120,000 | 6,422,000 | 6,271,000 | 6,358,000 |
| Operating Income | -4,928,000 | 2,958,000 | 4,266,000 | 4,414,000 | -6,017,000 |
| Other Income | -2,942,000 | 7,769,000 | -125,000 | -91,000 | -3,220,000 |
| Pre-tax Income | -7,870,000 | 10,727,000 | 4,141,000 | 4,323,000 | -9,237,000 |
| Income Tax | -1,982,000 | 3,047,000 | -915,000 | 433,000 | -1,536,000 |
| Net Income Continuous | -5,887,000 | 7,680,000 | 5,056,000 | 3,889,000 | -7,700,000 |
| Net Income Discontinuous | 5,314,000 | 4,000 | N/A | N/A | 7,318,000 |
| Minority Interests | 9,000 | 4,000 | 10,000 | 6,000 | 12,000 |
| Net Income | $-582,000 | $7,680,000 | $5,046,000 | $3,883,000 | $-395,000 |
| EPS Basic Total Ops | -0.10 | 1.38 | 0.91 | 0.69 | -0.06 |
| EPS Basic Continuous Ops | -1.06 | 1.38 | 0.91 | 0.69 | -1.31 |
| EPS Basic Discontinuous Ops | 0.95 | 0.00 | N/A | N/A | 1.25 |
| EPS Diluted Total Ops | -0.11 | 1.36 | 0.89 | 0.68 | -0.06 |
| EPS Diluted Continuous Ops | -1.04 | 1.36 | 0.89 | 0.68 | -1.29 |
| EPS Diluted Discontinuous Ops | 0.94 | 0.00 | N/A | N/A | 1.23 |
| EBITDA(a) | $-3,799,000 | $4,511,000 | $5,794,000 | $5,959,000 | $-4,610,000 |